Perspectives on biomarker testing and its influence on outcomes in patients with thyroid cancer

touchMDT for touchONCOLOLOGY Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes The multidisciplinary team  Pathologist: Dr Peter Sadow, USA Endocrinologist: Dr Antonio Matrone, Italy Oncologist: Dr Lori Wirth, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly and Bayer. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/personalized-approach-to-treatment-thyroid-cancer-biomarkers-and-targeted-therapies//